CVS Health Corporation with ticker code (CVS) have now 25 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The range between the high target price and low target price is between $93.00 and $48.01 and has a mean target at $66.26. Now with the previous closing price of $44.89 this indicates there is a potential upside of 47.6%. It’s also worth noting that there is a 50 day moving average of $53.46 and the 200 day MA is $59.70. The market cap for the company is 55.65B. The price for the stock stands currently at: $44.22 USD
The potential market cap would be $82,134,763,054 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 11.22, revenue per share of $290.20 and a 2.37% return on assets.
CVS Health Corporation, together with its subsidiaries, is a diversified health solutions company. The Company’s segments include Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other. Its Health Care Benefits offer a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare supplement plans, and Medicaid health care management services. Its Health Services provides a full range of pharmacy benefit management solutions, delivers health care services in its medical clinics, virtually, and in the home, and offers provider enablement solutions. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, and diagnostic testing.
